Staphylococcus aureus and its Bearing on Ophthalmic Disease

ABSTRACT

Purpose: To review antibiotic resistance associated with S. aureus endophthalmitis and the virulence of S. aureus.

Methods: Review of the current and prospective approaches for treating S. aureus endophthalmitis.

Results: Bacterial endophthalmitis remains to be a major threat for vision. S. aureus endophthalmitis specifically, carries a poor visual prognosis making early diagnosis and treatment crucial. Methicillin resistant Staphylococcus aureus (MRSA) endophthalmitis represents a significant number of S. aureus endophthalmitis cases. MRSA with reduced susceptibility to glycopeptide antibiotics such as vancomycin (vancomycin intermediate S. aureus, VISA) have also emerged in the ocular infections, and there has been a rise in S. aureus resistance to new and old generation fluoroquinolones that are commonly used for prophylaxis after intravitreal injections and intraocular surgeries.

Conclusions: With the rise in the number of penetrating procedures in the ophthalmology practice and the parallel rise in antibiotic resistance, prophylaxis and awareness of the antimicrobial resistance profiles remain crucial and the identification of novel antimicrobials is essential.

Keywords:

• Antibiotic resistance
• endophthalmitis
• methicillin
• Staphylococcus aureus
• virulence

DECLARATION OF INTEREST

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.